private equity valuations: current themes, challenges, … · private equity valuations: current...
TRANSCRIPT
Private Equity valuations: current themes,challenges, and the Updated Guidelines
*connectedthinking
1 October 2009
Ashley Coups, Nick Rea, Attul Karir
Slide 2PricewaterhouseCoopers LLP
October 2009
Contents and topics
• Introduction
• Key messages from today
• Current themes and challenges
• Principal changes within the Updated IPEVCG
• Option Value of Equity
• Conclusions
• Questions / Discussion
Slide 3PricewaterhouseCoopers LLP
October 2009
Section one
Introduction
Slide 4PricewaterhouseCoopers LLP
October 2009
Introduction
Nick ReaPartner, Financial Services ValuationPricewaterhouseCoopers LLP
Attul KarirAssistant Director, Financial Services ValuationPricewaterhouseCoopers LLP
Ashley CoupsUK Private Equity Assurance LeaderPricewaterhouseCoopers LLP
Slide 5PricewaterhouseCoopers LLP
October 2009
UK Private Equity v Principal Comparators
-40
-30
-20
-10
0
10
20
30
2008 3 Years 5 Years 10 Years
UK Private Equity FTSE All-Share WM Pension Fund Assets
Private equity valuation performance in 2008%
ch
an
ge
inv
alu
e
Source: BVCA Performance Measurement Survey 2008
Slide 6PricewaterhouseCoopers LLP
October 2009
UK Private Equity – Really That Good?
-40
-30
-20
-10
0
10
20
30
2008 3 Years 5 Years 10 Years
Total UK Private Equity Stable Currency
%ch
an
ge
inv
alu
e
Source: BVCA Performance Measurement Survey 2008
2008 performance adjusted for currency movements
Slide 7PricewaterhouseCoopers LLP
October 2009
Section two
Key messages from today
Slide 8PricewaterhouseCoopers LLP
October 2009
Key messages from today
1) Valuing investments remains difficult due to a lack of transactions and volatilemarkets
2) Valuation in 2008 was difficult – this year will not be any easier
3) The value of investments needs to be considered carefully given the rebound inequity markets in 2009 but challenging trading conditions (i.e. earnings will bescrutinised)
4) Potential covenant breaches can impact fair value and need to be considered
5) The Updated IPEVCG mean that the 12 month window for holding investments atcost no longer holds, and, in addition, the marketability discount needs to beconsidered in the multiple assessment
6) Valuations should not change as a result of the Updated Guidelines but compliancewith IFRS and US GAAP needs to be carefully reviewed (we understand that the USPE industry has asked for further clarification)
7) Investors are increasingly demanding in terms of regular and detailed information
8) DCF remains a valuation technique that is rarely used in this industry (and that isappropriate most of the time)
9) Cross-checks are critical and we, as auditors, need to use our judgement too
10)Decline in debt values do not automatically render equity worthless
Slide 9PricewaterhouseCoopers LLP
October 2009
Section three
Current themes and challenges
Slide 10PricewaterhouseCoopers LLP
October 2009
Valuation remains extremely challenging
Valuation is made difficult by:
- A lack of transactions
- Volatility in the price of securities
• Fair value is one of the hottest topicsfacing the alternatives sector today. Ever-increasing investor, regulatory andaccounting pressure for companies tofocus more attention on valuations hascoincided with the credit crunch.
• “There’s still some misconception thatthere is some magic number that’s theright one – and there isn’t,”
Nick Rea quote from FT article on 4 Dec08 “A magical mystery tour of privateequity valuations”
Slide 11PricewaterhouseCoopers LLP
October 2009
Valuation is currently challenging
FTSE 100 - Share pricing
0
1000
2000
3000
4000
5000
6000
7000
31Dec
07
31Jan
08
29 Feb
08
31M ar
08
30 Apr
08
31M ay
08
30 Jun
08
31Jul
08
31Aug
08
30 Sep
08
31Oct
08
30
Nov
31Dec
08
31Jan
09
28 Feb
09
31M ar
09
30 Apr
09
31M ay
09
30 Jun
09
31Jul
09
31Aug
09
Change in Share price
Jan 08 - Dec 08
Change in Share price
Jan 09 - Present
-31% 16%
Markets have rebounded…….
Slide 12PricewaterhouseCoopers LLP
October 2009
Valuation is currently challenging
FTSE 250 - Share pricing
0
2000
4000
6000
8000
10000
12000
31Dec
07
31Jan
08
29 Feb
08
31M ar
08
30 Apr
08
31M ay
08
30 Jun
08
31Jul
08
31Aug
08
30 Sep
08
31Oct
08
30
Nov
31Dec
08
31Jan
09
28 Feb
09
31M ar
09
30 Apr
09
31M ay
09
30 Jun
09
31Jul
09
31Aug
09
Change in Share price
Jan 08 - Dec 08
Change in Share price
Jan 09 - Present
-40% 44%
Particularly, mid-caps
Slide 13PricewaterhouseCoopers LLP
October 2009
The spotlight on valuations continues
• Communicate to investors where value is being added or lostover time in a Fund by reference to the fair value of portfoliocompanies;
• Make informed decisions on entry and exit by understandingupside and downside scenarios;
• Meet the requirements of the IPEVCG, IFRS and US GAAP andtherefore satisfy auditor review; and
• Produce regular valuations where investors trade on monthlynet asset value (NAV) in respect of open-ended funds.
Investors require regular and robust information and are increasingly demanding interms of analysis of investments. There are clear benefits from a rigorous valuationprocess, including the ability for investment managers to:
Slide 14PricewaterhouseCoopers LLP
October 2009
Common issues in 2008
• Can recent transactions be utilized as appropriatebenchmarks for portfolio company investments?
- consider the timing / nature of the transaction- transactions can be distressed, not entire markets!
Market ApproachComparableTransaction
• To what extent should recent stock market declinesimpact portfolio company valuations?
- the market cannot be ignored- consider use of averages (within reason!)- document adjustments to multiples
Market ApproachComparableCompany Multiple
MarketQuestions
ValuationMethodology
Slide 15PricewaterhouseCoopers LLP
October 2009
Anticipated challenges
Key Question: Are earnings maintainable?
• Focus in prior year was on updating multiples to reflect thedownturn in markets
• This year, emphasis may be on earnings estimates andwhether they have been updated to reflect recentperformance
• However multiples are also important now that control andmarketability can be reflected within the multiple
Slide 16PricewaterhouseCoopers LLP
October 2009
Anticipated challenges
• The different approach to marketability discounts should not impact valuations
• Has a control premium been factored in?
+V
alu
e
Discounts
• Lack ofmarketability
• Keymanagement ?
Premiums
• Control premium
Control Premium Minority Discount
Marketability Discount
Controlling Interest
Marketable Minority Interest
Non-Marketable Minority Interest
Slide 17PricewaterhouseCoopers LLP
October 2009
Section four
Principal changes within the Updated IPEVCG
Slide 18PricewaterhouseCoopers LLP
October 2009
Updated IPEVC Guidelines
Updated Guidelines should not result in achange in valuations
Fair value of portfoliocompanies
on8 Sept 09
Fair value of portfoliocompanies
on9 Sept 09
Slide 19PricewaterhouseCoopers LLP
October 2009
Updated IPEVC GuidelinesReleased in September 2009 and contains updated guidance such as:
1) Marketability discount has evolved from a standalone adjustment tobeing incorporated into determining appropriate multiple (plus noillustrative 10%, 20%, 30% examples)
2) Some recognition of control premium
3) There is no longer a reference to a 12 month ‘window’ for holdinginvestments at cost
4) No 25% impairment rule-of-thumb
5) Milestone analysis given more recognition
6) Guidance is included on valuing fund interests and secondarytransactions
7) DCF is appropriate for standalone mezzanine interests
8) A view that the whole market cannot be distressed
9) Absence of guidance on whether equity can have value even if debt isunderwater
Slide 20PricewaterhouseCoopers LLP
October 2009
Marketability discountsThe level at which the discount is applied should not impact fair value
Potential impact of updated approach to marketability discount
Previous IPEVCG Updated IPEVCG Updated IPEVCG
£m £m £m
EBITDA 1,248 1,248 1,248
EBITDA multiple 9.5x 7.6x 9.0x
Enterprise Value 11,856 9,485 11,290
Net Debt (9,213) (9,213) (9,213)
Gross Attributable EV 2,643 272 2,077
Marketability discount of 20% (529)
Equity Value 2,114 272 2,077
Fair Value of 1% equity stake 21 3 21
Cost 50 50 50
Write down implied £m (29) (47) (29)Write down implied % -58% -95% -58%
20% marketabilitydiscount applieddirectly to multiple(9.5x * 0.8 = 7.6x)
Marketability discountshould now be 5%not 20% applieddirectly to multiple(9.5x * 0.95 = 9.0x)
Slide 21PricewaterhouseCoopers LLP
October 2009
The US perspective
The U.S. Private Equity Valuation Guidelines were updated in March 2007 inresponse to FAS 157
• In September, 2006, the Financial Accounting Standards Board releasedStatement of Financial Accounting Standards No. 157, Fair ValueMeasurements
• The Updated U.S. Private Equity Valuation Guidelines were intended to assistmanagers in their estimation of fair value and were intended to be consistentwith FAS 157 and the AICPA Audit and Accounting Guide - Audits ofInvestment Companies
• The AICPA Guide’s definition of Investment Companies includes PrivateEquity Investors and requires investments to be reported at fair value
• Private Equity CFOs in the US have found the IPEVCG to be conceptualrather than prescriptive
• The U.S. Private Equity Valuation Guidelines already suggest thatmarketability discounts can be built into the multiple
• The U.S. Private Equity Valuation Guidelines are a less prominent referenceguide compared to the IPEVCG
Slide 22PricewaterhouseCoopers LLP
October 2009
Compliance with IFRS and US GAAP
The IPEVCG claim compliance “can be” achieved with IFRS and US GAAP
Compliance cannot be assumed,
particularly with respect to debt
investments (settlement versus
exchange)
Updated IPEVCG are more consistentwith IFRS approach to fair value
Compliance with US GAAPCompliance with IFRS
Slide 23PricewaterhouseCoopers LLP
October 2009
Section five
Option Value of Equity
Slide 24PricewaterhouseCoopers LLP
October 2009
Option Value of Equity / Fair Value of Debt
Is deduction of the face value of debt acceptable in the waterfall if there areindications that the fair value is lower?
• IPEVCG’s application of waterfall analysis considers settlement rather thantransfer of liability). This may not be consistent with US GAAP which follows atransfer notion for debt.
• This impacts the exit route: If a minority position is held, it may not belegitimate to assume a sale of a company and therefore the repayment of debtat face value.
• When debt is a relatively small portion of capital structure, face / book value ofdebt may represent a reasonable proxy.
100
1,000
1,100
200
5.5x
BV of Debt
FV of Equity
BEV
EBITDA
Implied Multiple
For example:
In this example, if the fair value of debt is 50%below its book value, the multiple onlydecreases to 5.3x
Slide 25PricewaterhouseCoopers LLP
October 2009
Fair Value of Debt
In the current market, many bonds issued by highly leveraged companies are tradingfor less than 50 cents on the dollar
“Since Nov 2008, atleast seven companiesowned by private-equityfirms, includingBlackstone’s Freescaleand Apollo’s Harrah’sEntertainment Inc, havesought to pare morethan $50 billion ofborrowings by offeringlenders the chance toexchange debt at adiscount for cash ornew securities.”
Source: 11 March 2009 Bloombergarticle: “Private Equity IndigestionComes with Bain Bloomin’ OnionDebts”
Slide 26PricewaterhouseCoopers LLP
October 2009
Does equity have value when debt is underwater?
If leverage / gearing is significant, fair value of debt may need to be considered
The example below illustrates a distressed portfolio company with an enterprisevalue
(£300m) that is lower than the face value of its debt (£400m)Enterprise Value Allocation Summary Enterprise Value Allocation Summary
ExpectedLow
Scenario (1)
High
Scenario (1)Cash Flow
Return
BusinessEnterprise Value
300£ 100£ 500£ 300£
Debt 300£ (2) 100£ 400£ £ 250
Equity -£ -£ 100£ 50£
(1)50% Probability
(2)Face value of debt is 400
Estimated Value
Multiple Outcome ApproachTraditional Waterfall
Fair
value
of debt
Option
value of
equity
Slide 27PricewaterhouseCoopers LLP
October 2009
Section six
Conclusions
Slide 28PricewaterhouseCoopers LLP
October 2009
Conclusions
1) Valuing investments remains difficult due to a lack of transactions and volatilemarkets
2) Valuation in 2008 was difficult – this year will not be any easier
3) The value of investments needs to be considered carefully given the rebound inequity markets in 2009 but challenging trading conditions (i.e. earnings will bescrutinised)
4) Potential covenant breaches can impact fair value and need to be considered
5) The Updated IPEVCG mean that the 12 month window for holding investments atcost no longer holds, and, in addition, the marketability discount needs to beconsidered in the multiple assessment
6) Valuations should not change as a result of the Updated Guidelines butcompliance with IFRS and US GAAP needs to be carefully reviewed (weunderstand that the US PE industry has asked for further clarification)
7) Investors are increasingly demanding in terms of regular and detailed information
8) DCF remains a valuation technique that is rarely used in this industry (and that isappropriate most of the time)
9) Cross-checks are critical and we, as auditors, need to use our judgement too
10)Decline in debt values do not automatically render equity worthless
Slide 29PricewaterhouseCoopers LLP
October 2009
Contact details
Nick ReaPartner, Financial Services ValuationPricewaterhouseCoopers LLPEmail: [email protected]: +44(0) 20 7212 3711
Attul KarirAssistant Director, Financial Services ValuationPricewaterhouseCoopers LLPEmail: [email protected]: +44(0) 20 7213 4952
Ashley CoupsUK Private Equity Assurance LeaderPricewaterhouseCoopers LLPEmail: [email protected]: +44(0) 20 7804 9609
This publication has been prepared for general guidance on matters of interest only, and does not constituteprofessional advice. You should not act upon the information contained in this publication without obtaining specificprofessional advice. No representation or warranty (express or implied) is given as to the accuracy or completenessof the information contained in this publication, and, to the extent permitted by law, PricewaterhouseCoopers LLP,its members, employees and agents do not accept or assume any liability, responsibility or duty of care for anyconsequences of you or anyone else acting, or refraining to act, in reliance on the information contained in thispublication or for any decision based on it.
© 2009 PricewaterhouseCoopers LLP. All rights reserved. ‘PricewaterhouseCoopers’ refers toPricewaterhouseCoopers LLP (a limited liability partnership in the United Kingdom) or, as the context requires, thePricewaterhouseCoopers global network or other member firms of the network, each of which is a separate andindependent legal entity.